Torsdag 4 December | 11:20:51 Europe / Stockholm

Kalender

Est. tid*
2026-02-17 08:20 Bokslutskommuniké 2025
2025-11-18 - Kvartalsrapport 2025-Q3
2025-11-13 - Extra Bolagsstämma 2025
2025-08-19 - Kvartalsrapport 2025-Q2
2025-05-20 - Kvartalsrapport 2025-Q1
2025-04-25 - X-dag ordinarie utdelning KAV 0.00 SEK
2025-04-24 - Årsstämma
2025-02-18 - Bokslutskommuniké 2024
2024-11-19 - Kvartalsrapport 2024-Q3
2024-08-20 - Kvartalsrapport 2024-Q2
2024-05-21 - Kvartalsrapport 2024-Q1
2024-05-17 - X-dag ordinarie utdelning KAV 0.00 SEK
2024-04-25 - Årsstämma
2024-02-20 - Bokslutskommuniké 2023
2023-11-21 - Kvartalsrapport 2023-Q3
2023-11-13 - Extra Bolagsstämma 2023
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-23 - Kvartalsrapport 2023-Q1
2023-04-28 - X-dag ordinarie utdelning KAV 0.00 SEK
2023-04-27 - Årsstämma
2023-02-21 - Bokslutskommuniké 2022
2022-11-15 - Kvartalsrapport 2022-Q3
2022-08-09 - Kvartalsrapport 2022-Q2
2022-05-17 - Kvartalsrapport 2022-Q1
2021-09-06 - Split KAV 1:1000

Beskrivning

LandSverige
ListaSpotlight
SektorFinans
IndustriInvesteringar
Katalysen Ventures är ett svenskt investeringsbolag som investerar i tidiga tillväxtbolag och stödjer deras utveckling genom kapital och rådgivning. Bolaget samarbetar med entreprenörer inom olika sektorer, med särskilt fokus på teknikdrivna affärsmodeller som fintech. Bolaget är verksamt inom den europeiska markanden. Katalysen Ventures grundades 2016 och har sitt huvudkontor i Stockholm, Sverige.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-11-14 07:12:07

Yesterday, Thursday 13 November 2025, Katalysen Ventures AB (publ) held an Extraordinary General Meeting at the company's premises at Birger Jarlsgatan 22 in Stockholm. Below is a summary of the resolution adopted at the meeting. The resolution was passed unanimously.

Authorisation for the Board of Directors to resolve on share issues

The Meeting resolved to approve the proposal in accordance with the Board's recommendation. The authorisation permits the Board, with or without preferential rights for existing shareholders, to resolve on the issuance of shares, warrants or convertible instruments to the extent set out in the presented proposal.

Adopted proposal:

The Board of Directors proposes that the general meeting resolve to authorize the Board, on one or more occasions until the next annual general meeting, with or without deviation from the shareholders' preferential rights, to resolve on the issue of shares or warrants. Such issues may be made with or without provisions regarding consideration in kind, set-off, or other conditions.

The total number of shares that may be issued, or, in the case of warrants, may be added upon exercise under this authorization, shall amount to a maximum of 1,243,067, corresponding to a total maximum dilution of approximately 12 percent based on the current number of registered shares in the company. The purpose of the authorization is to enable the company to raise working capital and to carry out acquisitions of companies or business assets. To the extent the authorization is used for issues with deviation from shareholders' preferential rights, such issues shall be carried out on market terms.

The company's CEO shall be authorized to make such minor formal adjustments to the resolution as may be required in connection with registration with the Swedish Companies Registration Office (Bolagsverket).